- Previous Close
37.18 - Open
37.08 - Bid 37.24 x --
- Ask 37.50 x --
- Day's Range
37.08 - 37.08 - 52 Week Range
35.16 - 101.60 - Volume
911 - Avg. Volume
120,256 - Market Cap (intraday)
481.792M - Beta (5Y Monthly) 1.41
- PE Ratio (TTM)
-- - EPS (TTM)
-8.31 - Earnings Date Aug 20, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
87.45
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products. It also provides professional health care services. The company sells its products to online mail-order pharmacies, and private individuals under the PromoFarma by DocMorris, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
corporate.docmorris.com/en1,453
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: DOCM.SW
View MorePerformance Overview: DOCM.SW
Trailing total returns as of 9/10/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DOCM.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DOCM.SW
View MoreValuation Measures
Market Cap
478.97M
Enterprise Value
686.55M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.43
Price/Book (mrq)
1.20
Enterprise Value/Revenue
0.68
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-9.70%
Return on Assets (ttm)
-4.98%
Return on Equity (ttm)
-21.76%
Revenue (ttm)
1B
Net Income Avi to Common (ttm)
-97.26M
Diluted EPS (ttm)
-8.31
Balance Sheet and Cash Flow
Total Cash (mrq)
195.11M
Total Debt/Equity (mrq)
100.76%
Levered Free Cash Flow (ttm)
-78.2M